Cell Death and Disease (Oct 2021)
Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
- Dongyan Liu,
- Xiaonan Hou,
- Wangyu Wu,
- Valentina Zafagnin,
- Yunjian Li,
- Cristina Correia,
- Zhiyang Zhao,
- Chenggang Zhao,
- Zhirong Liu,
- Tao Zhang,
- Zhiyou Fang,
- Hongzhi Wang,
- Chao Xu,
- Saravut J. Weroha,
- Scott H. Kaufmann,
- Haiming Dai
Affiliations
- Dongyan Liu
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Xiaonan Hou
- Division of Medical Oncology, Mayo Clinic
- Wangyu Wu
- Second Affiliated Hospital of Anhui Medical University
- Valentina Zafagnin
- Division of Medical Oncology, Mayo Clinic
- Yunjian Li
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Cristina Correia
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
- Zhiyang Zhao
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Chenggang Zhao
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Zhirong Liu
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Tao Zhang
- Second Affiliated Hospital of Anhui Medical University
- Zhiyou Fang
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Hongzhi Wang
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- Chao Xu
- University of Science and Technology of China
- Saravut J. Weroha
- Division of Medical Oncology, Mayo Clinic
- Scott H. Kaufmann
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
- Haiming Dai
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences
- DOI
- https://doi.org/10.1038/s41419-021-04219-0
- Journal volume & issue
-
Vol. 12,
no. 11
pp. 1 – 1
Abstract
No abstracts available.
